ST. LOUIS, Aug. 16, 2012 (GLOBE NEWSWIRE) -- Veran Medical Technologies, developers of the next generation of minimally invasive delivery of interventional oncology therapies, announced today that Jason Pesterfield has been appointed President and Chief Executive Officer and a member of the Board of Directors.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=14073
"Jason Pesterfield brings to Veran over 17 years of in-depth experience in the medical device navigation field," said Greg Johnson, Veran's Chairman of the Board. "He has an impressive track record of leading navigation business, focused on transforming an early stage technology into a profitable, high growth business. Jason has proved the successful execution of positioning business strategically for profitable growth, and we have great confidence that he will use his talent and experience to lead Veran to the next level."
"Veran Medical Technologies has a solid foundation and tremendous opportunity to grow and deliver," Pesterfield said. "Veran is already a recognized contributor in the next generation of navigation technology, with solid success in gaining market position." He noted that Veran is widely appreciated for its capabilities to generate innovative products and customized solutions.
Pesterfield was previously with Stryker Corporation, where he held the position of Global Vice President and General Manager, in charge of the Global Surgical Navigation Business and a member of Stryker Instrument's $1.5 billion executive team. Through his leadership, the business transformed from an early stage technology into a profitable high growth business. His leadership contributed to strategic attributes extending across an $8 billion corporation comprised of 21,000 employees. He also served in global leadership and innovation, sales and customer care leadership, global marketing and research and development. Pesterfield holds a BBA in Marketing from the University of Nebraska.
About Veran Medical Technologies, Inc. Veran Medical Technologies is a privately held company led by a team of innovators focused on developing the next generation of minimally invasive delivery of interventional oncology therapies. Veran has built several clinical products upon its ig4™ platform technology, which uses proprietary 4D registration capabilities for targeting lesions within the human body. The company believes that by enabling minimally invasive early stage diagnosis, it can increase patient survival and potentially lower healthcare costs. Veran Medical Technologies is headquartered in St. Louis, MO.
The Veran Medical Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=14072
